Revision as of 02:36, 27 February 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (← Previous edit |
Latest revision as of 01:59, 28 January 2022 edit undoBattyBot (talk | contribs)Bots1,936,174 editsm →top: Fixed CS1 errors: extra text: volume and general fixesTag: AWB |
(25 intermediate revisions by 18 users not shown) |
Line 1: |
Line 1: |
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 413056395 |
|
|
|
| Watchedfields = changed |
⚫ |
| ImageFile1 = Piperinsäure.svg |
|
|
⚫ |
| verifiedrevid = 416140319 |
|
| IUPACName = <small>5-(3,4-methylenedioxyphenyl)-2,4-pentadienoic acid</small> |
|
|
⚫ |
| ImageFile1 = Piperinsäure.svg |
⚫ |
| Section1 = {{Chembox Identifiers |
|
|
|
| PIN = (2''E'',4''E'')-5-(2''H''-1,3-Benzodioxol-5-yl)penta-2,4-dienoic acid |
⚫ |
| CASNo = 136-72-1 |
|
|
⚫ |
|Section1={{Chembox Identifiers |
⚫ |
| CASNo_Ref = {{cascite}} |
|
|
⚫ |
| CASNo = 136-72-1 |
|
| SMILES = OC(=O)\C=C\C=C\c1ccc2OCOc2c1 |
|
|
⚫ |
| CASNo_Ref = {{cascite|correct|??}} |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = GFG3FLA9UR |
|
|
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEBI = 37316 |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 332122 |
|
|
| EINECS = 226-118-4 |
|
|
| PubChem = 5370536 |
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
|
| ChemSpiderID = 4521337 |
|
|
| SMILES = C1OC2=C(O1)C=C(C=C2)/C=C/C=C/C(=O)O |
|
|
| InChI = 1/C12H10O4/c13-12(14)4-2-1-3-9-5-6-10-11(7-9)16-8-15-10/h1-7H,8H2,(H,13,14)/b3-1+,4-2+ |
|
|
| InChIKey = RHBGITBPARBDPH-ZPUQHVIOBF |
|
|
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|
|
| StdInChI = 1S/C12H10O4/c13-12(14)4-2-1-3-9-5-6-10-11(7-9)16-8-15-10/h1-7H,8H2,(H,13,14)/b3-1+,4-2+ |
|
|
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|
|
| StdInChIKey = RHBGITBPARBDPH-ZPUQHVIOSA-N |
|
|
| RTECS = |
|
|
| MeSHName = C017637 |
|
}} |
|
}} |
|
| Section2 = {{Chembox Properties |
|
|Section2={{Chembox Properties |
|
| C=12|H=10|O=4 |
|
| C=12 | H=10 | O=4 |
|
| Density = |
|
| Density = |
|
| MeltingPtC = |
|
| MeltingPtC = |
|
| BoilingPt = ''decomposes'' |
|
| BoilingPt = ''decomposes'' |
|
| pKa = |
|
| pKa = |
|
}} |
|
}} |
|
}} |
|
}} |
|
'''Piperic acid''' is a chemical often obtained by the ]-] of the ] ]<ref>{{cite book | url = http://books.google.com/?id=iyzlMSPp-EMC&pg=PA327 | page = 327 | isbn = 9780470741672 | author = Paul M. Dewick. | year = 2009 | publisher = A John Wiley & Sons | location = Chichester | title = Medicinal natural products : a biosynthetic approach }}</ref> from ]<ref>http://chestofbooks.com/health/aromatherapy/The-Volatile-Oils-Vol1/Heliotropin.html</ref>, followed by ]ification of the corresponding ].<ref>http://www.erowid.org/archive/rhodium/chemistry/3base/piperonal.pepper/degradation.piperine/index.html</ref> Piperic acid is an intermediate in the synthesis of other compounds such as ], and as-such may be used to produce ], ] flavorants and ] as well as other useful compounds. |
|
'''Piperic acid''' is a chemical often obtained by the ]-] of the ] ]<ref>{{cite book | url = https://books.google.com/books?id=iyzlMSPp-EMC&pg=PA327 | page = 327 | isbn = 978-0-470-74167-2 | author = Paul M. Dewick. | year = 2009 | publisher = A John Wiley & Sons | location = Chichester | title = Medicinal natural products : a biosynthetic approach }}</ref> from ],<ref>{{cite book | title = The Volatile Oils| volume = 1 | author = E. Gildemeister | url = http://chestofbooks.com/health/aromatherapy/The-Volatile-Oils-Vol1/Heliotropin.html}}</ref> followed by ]ification of the corresponding ]. Piperic acid is an intermediate in the synthesis of other compounds such as ], and as-such may be used to produce ], ] flavorants and ] as well as other useful compounds. |
|
|
|
|
|
==Preparation== |
|
==Preparation== |
|
'''Piperic acid''' can be prepared from the commercially-available alkaloid ], a cyclic ] containing a ] group, by reacting it with a ] such as ], then acidifying the formed piperate salt with ] or another acid. The ] compound piperidine is given off during the base-hydrolysis of piperine and as-such, safety precautions should be taken. |
|
Piperic acid can be prepared from the commercially-available alkaloid ], a cyclic ] containing a ] group, by reacting it with a ] such as ], then acidifying the formed piperate salt with ] or another acid. The ] compound piperidine is given off during the base-hydrolysis of piperine and as-such, safety precautions should be taken. |
|
|
|
|
|
:]]] |
|
:]]] |
|
|
|
|
|
==Reactions== |
|
==Reactions== |
|
Reaction of piperic acid with strong oxidizers such as ] or ], or a halogen such as ] followed by ] causes the ] of the double-bonds, yielding ] via ]<ref>http://www.freepatentsonline.com/5095128.html, Preparation process for piperonal, US Patent No. 5095128</ref><ref>http://www.erowid.org/archive/rhodium/chemistry/3base/piperonal.pepper/cleavage.piperic_acid/index.html</ref>. Piperonal has many uses in industry and is itself a precursor to a good subsection of other chemicals, including the ]ic ] ] and ], collectively known by the street name ecstasy. |
|
Reaction of piperic acid with strong oxidizers such as ] or ], or a halogen such as ] followed by ] causes ] of the double-bonds, yielding ] and ].<ref>{{Cite patent | country = US | title = Preparation process for piperonal | number = 5095128 }}</ref> Piperonal has many uses in industry and is itself a precursor to a good subsection of other chemicals. On reduction with sodium ] piperic acid forms α- and β-], C<sub>12</sub>H<sub>12</sub>O<sub>4</sub>, and the latter can take up two further atoms of hydrogen to produce ]. |
|
:] |
|
|
|
|
|
|
==See also== |
|
==See also== |
Line 39: |
Line 58: |
|
<references /> |
|
<references /> |
|
|
|
|
|
] |
|
] |
|
|
] |
|
|
|
|
] |
|